A career public servant, Tanya Potashnik possesses a breadth of knowledge in the area of pharmaceutical environment in Canada both from a provincial and Federal perspective. Tanya is currently the Director of policy and economic analysis at the Patented Medicine Prices Review Board. Prior to this role, Tanya served as manager and senior economist at the Board in charge of, among other things, the National Prescription Drug Utilization Information System (NPDUIS) initiative. Tanya has also held policy and management positions in Health Canada and the BC Ministry of Health. Tanya received her Bachelors of Arts from the University of Winnipeg in Economics and Business and received her Masters of Arts from the University of Victoria in economics.